NPPB and hypertensive disorder: To our best knowledge, no comprehensive overview of the evidence for the prognostic value of cardiac biomarkers, especially BNP/NT-proBNP and troponin T and I, on major adverse cardiac events (MACE) in hypertension has been reported, despite the widely accepted and growing interest in the use of circulating plasma biomarkers for risk stratification.